Skip to main content
Loading

Bispecific-, Biparatopic-, and T-cell receptor mimic ADCs: New players to mitigate off-target effects?

18 Jun 2025
Toxicity & Off-Target Effects
  • General: How do the targeting mechanisms of BsADCs, BpADCs, and TCRm-ADCs fundamentally differ in achieving tumor selectivity?
  • BsADCs: How critical is the spatial proximity and co-expression of two antigens for BsADC function?
  • BpADCs: How does dual-epitope targeting impact internalization efficiency?
  • TCRm-ADCs: How can we mitigate the risks of off-target cross-reactivity in TCRm-ADC development? Are TCRm-Abs a realistic opportunity for ADCs?
Industry Expert
Oliver Hill, Senior Director of Protein Engineering - Yumab

YUMAB